The Motley Fool

Incyte Aktie (NASDAQ:INCY)

Incyte isn't the only drugmaker with a JAK inhibitor, but Jakafi's differentiation as a JAK1 and JAK2 inhibitor has helped the company stay on top of the treatment paradigm for myelofibrosis.

$74.34 $0.95 (1.3%) Donnerstag, 19. Mai 2022 um 22:00:00 Mitteleuropäische Sommerzeit

About

Last updated 19-05-2022, 10:00:00pm CEST
Aktueller Kurs $74.34
Veränderung $0.95 (1.3%)
Schlusskurs $74.34
Eröffnung $73.34
Geld $71.00
Brief $85.00
Tagesspanne $72.49 - $74.83
52-Wochen-Spanne $61.91 - $88.26
Volumen 1,417,597
Durchschn. Volumen 1,452,162
Marktkapitalisierung $16,256,252,757.00
EPS (roll. Hochrechn.) $4.23

Related Articles